SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001839882-23-001530
Filing Date
2023-01-26
Accepted
2023-01-26 14:48:49
Documents
2
Period of Report
2023-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 xia-form3_012523.html 3  
1 FORM 3 xia-form3_012523.xml 3 1606
2 LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS ex-24.htm EX-24 9011
  Complete submission text file 0001839882-23-001530.txt   12185
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6 SHENNONG ROAD, TORCH DEVELOPMENT ZONE ZHONGSHAN, GUANGDONG F4 528437
Business Address
Xia Yu (Reporting) CIK: 0001963544 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 23557100